What is Chimerix Inc (CMRX) stock price today?

Chimerix Inc (CMRX) currently trades at $8.54 per share. The stock has a market capitalization of $801.08M and a P/E ratio of —x.

Is CMRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Chimerix Inc has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Chimerix Inc's revenue and earnings?

Chimerix Inc has trailing twelve-month (TTM) revenue of $212000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.99.

CMRX

Chimerix Inc

NASDAQ: CMRX · HEALTHCARE · BIOTECHNOLOGY

$8.54

+0.00% today

Updated 2026-04-29

Market cap

$801.08M

P/E ratio

—

P/S ratio

3,778.70x

EPS (TTM)

$-0.99

Dividend yield

—

52W range

$0 – $0

Volume

1.4M

Market cap

$801.08M

P/E ratio

—

P/S ratio

3,778.70x

EPS (TTM)

$-0.99

Dividend yield

—

52W range

$0 – $0

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$8.53

-0.12%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 1,325.00% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-19.43M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$1.98M	$33.82M	$324000.00	$212000.00	$212000.00
Net income	$-255.79M	$172.17M	$-82.09M	$-88.39M	$-22.95M
EPS	—	—	—	—	$-0.99
Free cash flow	$-100.14M	$-46.94M	$-69.18M	$-75.26M	$-19.43M
Profit margin	-12,925.47%	509.01%	-25,337.96%	-41,691.98%	—

Recent insider activity

Date	Insider	Type	Shares	Price
2025-04-21	VAKIENER, VICTORIA	Sale	60,000	—
2025-04-21	VAKIENER, VICTORIA	Sale	50,000	—
2025-04-21	VAKIENER, VICTORIA	Sale	35,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CMRX	$801.08M	29	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Chimerix Inc trades at $8.54. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $212000.00.

Frequently asked questions

What is Chimerix Inc's stock price?

Chimerix Inc (CMRX) trades at $8.54.

Is Chimerix Inc overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell).

What is the price target of Chimerix Inc (CMRX)?

The analyst target price is $8.53, representing -0.1% downside from the current price of $8.54.

What is Chimerix Inc's revenue?

TTM revenue is $212000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio3,778.70x

ROE-56.20%

Beta-0.18

50D MA$7.31

200D MA$3.09

Shares out0.09B

Float0.08B

Short ratio—

Avg volume1.4M

Performance

1 week+0.00%

1 month+0.00%

3 months+0.00%

YTD+0.00%

1 year+0.00%

3 years—

5 years—

Compare

CMRX vs LLY →CMRX vs JNJ →CMRX vs ABBV →Stock screener →